More accurate LDL-C calculation: Externally validated, guideline endorsed

Adam J. Brownstein, Seth S. Martin

Research output: Contribution to journalArticle

Abstract

Low density lipoprotein-cholesterol (LDL-C) serves as the primary target of therapy for preventing atherosclerotic cardiovascular disease (ASCVD). Recently released European and American guidelines on lipid management recommend attaining very low LDL-C levels (<1.8 mmol/L or even lower) in high and very-high risk patients. Therefore, utilizing an accurate means for determining LDL-C, especially at such low values, is of paramount importance to inform the best clinical decisions and use of effective therapies. This review compares the different methods of determining LDL-C, including the various forms of direct measurement and most commonly used calculations. This review discusses the evidence behind these methods in different populations of patients and in the fasting versus non-fasting state. The Martin/Hopkins method is the preferred method for determining LDL-C as it is the most accurate and widely applicable method. It is especially useful in patients with low LDL-C levels < 1.8 mmol/L (<70 mg/dL) and high triglyceride levels between 1.7 and 4.5 mmol/L (150–399 mg/dL), and is reliable in the non-fasting state.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalClinica Chimica Acta
Volume506
DOIs
StatePublished - Jul 2020

Keywords

  • Cardiovascular disease
  • Friedewald equation
  • Low density lipoprotein-cholesterol (LDL-C)
  • Martin-Hopkins equation
  • Non-fasting lipid panel
  • PCSK9 inhibitors
  • Statins

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'More accurate LDL-C calculation: Externally validated, guideline endorsed'. Together they form a unique fingerprint.

  • Cite this